methyl nicotinate has been researched along with Schizophrenia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ross, BM | 1 |
| Hoffman, WF; Messamore, E; Yao, JK | 1 |
| Hoffman, WF; Janowsky, A; Messamore, E | 1 |
| Glen, I; Maclean, R; Roberts, SJ; Ross, BM; Ward, PE | 1 |
| Hughes, B; Ross, BM; Seeman, M; Turenne, S; Warsh, JJ | 1 |
| Baur, K; Berger, G; Riemann, S; Rosburg, T; Rudolph, N; Sauer, H; Smesny, S | 1 |
| Baur, K; Rosburg, T; Rudolph, N; Sauer, H; Smesny, S | 1 |
| Glen, AI; Glen, EM; Sutherland, J; Ward, PE | 1 |
| Peet, M; Ramchand, CN; Shah, SH; Vankar, GK | 1 |
1 trial(s) available for methyl nicotinate and Schizophrenia
| Article | Year |
|---|---|
Niacin sensitivity and the arachidonic acid pathway in schizophrenia.
Topics: Adult; Anti-Inflammatory Agents; Arachidonic Acid; Dose-Response Relationship, Drug; Erucic Acids; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Female; Flushing; Humans; Male; Middle Aged; Models, Biological; Niacin; Nicotinic Acids; Regression Analysis; Schizophrenia; Skin; Skin Tests | 2010 |
8 other study(ies) available for methyl nicotinate and Schizophrenia
| Article | Year |
|---|---|
Methylnicotinate stimulated prostaglandin synthesis in patients with schizophrenia: A preliminary investigation.
Topics: Adult; Case-Control Studies; Female; Humans; Male; Middle Aged; Nicotinic Acids; Prostaglandin D2; Schizophrenia; Skin; Vasodilator Agents | 2018 |
The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Flushing; Hemodynamics; Humans; Laser-Doppler Flowmetry; Male; Middle Aged; Niacin; Nicotinic Acids; Schizophrenia; Signal Transduction; Skin; Ultrasonography; Vasodilation | 2003 |
On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Analysis of Variance; Bipolar Disorder; Chi-Square Distribution; Fatty Acids; Female; Flushing; Humans; Male; Middle Aged; Nicotinic Acids; Psychotic Disorders; Schizophrenia; Statistics, Nonparametric | 2003 |
Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry.
Topics: Adult; Analysis of Variance; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Laser-Doppler Flowmetry; Lithium; Male; Mental Disorders; Middle Aged; Nicotinic Acids; Regional Blood Flow; Schizophrenia; Time Factors; Vasodilation | 2004 |
Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia.
Topics: Acute Disease; Adult; Case-Control Studies; Female; Flushing; Humans; Male; Niacin; Nicotinic Acids; Prostaglandins; Recurrence; Schizophrenia; Signal Transduction; Skin | 2005 |
Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia.
Topics: Adult; Arachidonic Acids; Biomarkers; Brain; Cannabinoids; Cross-Sectional Studies; Dronabinol; Drug Interactions; Female; Humans; Lipid Metabolism; Male; Niacin; Nicotinic Acids; Prostaglandins; Regional Blood Flow; Schizophrenia; Skin; Skin Tests; Vasodilation | 2007 |
Niacin skin flush in schizophrenia: a preliminary report.
Topics: Adult; Arachidonic Acid; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Erythrocyte Membrane; Feasibility Studies; Female; Flushing; Humans; Male; Middle Aged; Nicotinic Acids; Pilot Projects; Prostaglandin D2; Psychiatric Status Rating Scales; Reference Values; Schizophrenia; Sensitivity and Specificity; Skin; Vasodilation | 1998 |
Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin.
Topics: Adult; Dose-Response Relationship, Drug; Female; Flushing; Humans; Male; Middle Aged; Nicotinic Acids; Patch Tests; Schizophrenia; Sensitivity and Specificity | 2000 |